H

Hyphens Pharma International Ltd
SGX:1J5

Watchlist Manager
Hyphens Pharma International Ltd
SGX:1J5
Watchlist
Price: 0.35 SGD Market Closed
Market Cap: 108.2m SGD

Hyphens Pharma International Ltd
Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Hyphens Pharma International Ltd
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
H
Hyphens Pharma International Ltd
SGX:1J5
Revenue
S$185.3m
CAGR 3-Years
9%
CAGR 5-Years
8%
CAGR 10-Years
N/A
WAVE Life Sciences Ltd
NASDAQ:WVE
Revenue
$109.2m
CAGR 3-Years
197%
CAGR 5-Years
53%
CAGR 10-Years
92%
Haw Par Corporation Ltd
SGX:H02
Revenue
S$253m
CAGR 3-Years
14%
CAGR 5-Years
7%
CAGR 10-Years
4%
I
IX Biopharma Ltd
SGX:42C
Revenue
S$7.8m
CAGR 3-Years
-19%
CAGR 5-Years
51%
CAGR 10-Years
N/A
No Stocks Found

Hyphens Pharma International Ltd
Glance View

Market Cap
108.1m SGD
Industry
Pharmaceuticals

Hyphens Pharma International Ltd. is an investment holding company, which engages in the provision of specialty pharmaceutical and consumer healthcare products. The firm's principal activities are those of an investment holding company and provision of management services. The firm's segments include specialty pharma principals, proprietary brands, and medical hypermart and digital. The specialty pharma principals segment is engaged in the business of marketing and selling a range of specialty pharmaceutical products with exclusivity in the relevant ASEAN countries. The proprietary brands segment is engaged in the business of developing, marketing and selling its own proprietary range of dermatological products and health supplement products. The medical hypermart and digital segment is a wholesaler of pharmaceuticals and medical supplies in Singapore, which the Company and its subsidiaries position itself as a medical hypermart for healthcare professionals, healthcare institutions and retail pharmacies.

1J5 Intrinsic Value
HIDDEN
Show

See Also

What is Hyphens Pharma International Ltd's Revenue?
Revenue
185.3m SGD

Based on the financial report for Jun 30, 2025, Hyphens Pharma International Ltd's Revenue amounts to 185.3m SGD.

What is Hyphens Pharma International Ltd's Revenue growth rate?
Revenue CAGR 5Y
8%

Over the last year, the Revenue growth was -5%. The average annual Revenue growth rates for Hyphens Pharma International Ltd have been 9% over the past three years , 8% over the past five years .

Back to Top